FdaApplication
ANDA 207124
Identifiers
- fda_app_no: ANDA207124
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2022-09-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL |
| DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL |
| DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL |
3 products